Gastrointestinal Cancer
Case Reports
Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic index
Conference Coverage
Pancreatic cancer has a pancreatopathy distinct from type 2 diabetes
WASHINGTON – The relationship between pancreatic cancer and diabetes is complex, but certain pathological markers differentiate them.
From the Journals
Rural cancer patients report faster care than urban counterparts
In contrast to previous studies, urban patients reported longer delays in care, scoring “Getting Care Quickly” 2.27 points lower than rural...
Conference Coverage
PREOPANC-1: Early findings suggest benefit with preop chemo in pancreatic cancer
Preliminary findings from the PREOPANC-1 trial suggest preoperative chemotherapy improves outcomes in pancreatic cancer patients.
Conference Coverage
Four phase 3 studies highlighted at ASCO mark progress in GI cancers
Prodige 7 addressed a long-unanswered question about the value of HIPEC and demonstrated that less is more when it comes to the treatment of...
Conference Coverage
Prodige 7: No survival benefit with HIPEC for advanced colorectal cancer
HIPEC after surgery for colorectal peritoneal carcinomatosis provides no survival benefit and may cause harm, according to Prodige 7 trial...
Latest News
ACS: Start colorectal cancer screening at age 45
The updated guideline is based on an increasing burden of colorectal cancer in younger individuals.
Conference Coverage
IMPACT study: Matched targeted therapy improves survival in advanced cancer
Patients with advanced cancer who received matched targeted therapy had better disease control rates, progression-free survival, and overall...
Conference Coverage
Barrett’s segment length, low-grade dysplasia tied to increased risk of neoplastic progression
A Dutch study found that age at baseline endoscopy, length of Barrett’s segment, and low-grade dysplasia were significant predictors of neoplastic...
Conference Coverage
Tumor analysis: Test all MSI-high patients for Lynch Syndrome
High microsatellite instability predicts LS across numerous tumor types, indicating a need for expanded LS testing in MSI-high patients.
Conference Coverage
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
CHICAGO - Dr. Todd Yezefski discusses the drivers of cost disparities and implications for policy makers.